Oil-in-water liposomal emulsions for vaccine delivery

Methods in Enzymology

Volumn 373, Issue , 2003, Pages 34-50

  Matyas, Gary R ^a   Muderhwa, Jean M ^a   Alving, Carl R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMYRISTOYLGLYCERO 3 PHOSPHO(1 GLYCEROL); ASPARAGINYLLYSYLPROLYLLYSYLASPARTYLGLUTAMYLLEUCYLASPARTYLTYROSYLGLUTAMYL ASPARAGINYLASPARTYLISOLEUCYLGLUTAMYLLYSYLLYSYLCYSTEINYLLYSYLMETHIONYLGLUTAMYL LYSYLCYSTEINYLSERINE; BOVINE SERUM ALBUMIN; CHLOROFORM; CHOLESTEROL; CIRCUMSPOROZOITE PROTEIN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; KALLIKREIN; LIPOSOME; LYSOPHOSPHOCHOLINE; LYSOPHOSPHOGLYCEROL; MINERAL OIL; OVALBUMIN; OVOTRANSFERRIN; PHOSPHOLIPID DERIVATIVE; PHOSPHORYL LIPID A; PROSTATE SPECIFIC ANTIGEN; PROTEIN R32NS1; PROTOZOAL PROTEIN; RICIN A; UNCLASSIFIED DRUG; VACCINE; WATER;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; DRUG STABILITY; DRUG SYNTHESIS; EMULSION; PRIORITY JOURNAL; ANIMAL; HUMAN; IMMUNOLOGY; METHODOLOGY;

BOVINAE;

ANIMALS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; LIPOSOMES; VACCINES;

EID: 1342333037     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (23)

1. R. L. Richards, M. Rao, N. M. Wassef, G. M. Glenn, S. W. Rothwell, and C. R. Alving, Infect. Immun. 66, 2859 (1998).
2. K. White, U. Krzych, D. M. Gordon, T. G. Porter, R. L. Richards, C. R. Alving, C. D. Deal, M. Hollingdale, C. Silverman, D. R. Sylvester, W. R. Ballou, and M. Gross, Vaccine 11, 1341 (1993).
3. D. G. Heppner, D. M. Gordon, M. Gross, B. Welde, W. Leitner, U. Krzych, I. Schneider, R. A. Wirtz, R. L. Richards, A. Trofa, T. Hall, J. C. Sadoff, P. Boerger, C. R. Alving, D. R. Sylvester, T. G. Porter, and W. R. Ballou, J. Infect. Dis. 174, 361 (1996).
4. C. R. Alving and N. M. Wassef, AIDS Res. Hum. Retrovir. 10(suppl. 2), S91 (1994).
5. C. R. Alving, V. Koulchin, G. M. Glenn, and M. Rao, Immunol. Rev. 145, 5 (1995).
6. L. F. Fries, D. M. Gordon, R. L. Richards, J. E. Egan, M. R. Hollingdale, M. Gross, C. Silveman, and C. R. Alving, Proc. Natl. Acad. Sci. USA 89, 358 (1992).
7. R. Glück, in "Vaccine Design: The Subunit and Adjuvant Approach" (M. F. Powell and M. J. Newman, eds.) p. 325, Plenum Press, New York, 1995.
8. B. Mengiardi, R. Berger, M. Just, and R. Glück, Vaccine 13, 1306 (1995).
9. J. M. Muderhwa, G. R. Matyas, L. E. Spitler, and C. R. Alving, J. Pharm. Sci. 88, 1332 (1999).
10. D. T. Harris, G. R. Matyas, L. G. Gomella, E. Talor, M. D. Winship, L. E. Spitler, and M. J. Mastrangelo, Semin. Oncol. 26, 439 (1999).
11. N. M. Wassef, C. R. Alving, and R. L. Richards, Immunomethods 4, 217 (1994).
12. C. R. Alving, S. Shichijo, I. Mattsby-Baltzer, R. L. Richards, and N. M. Wassef, in "Liposome Technology," 2nd Edn, Vol. 3 (G. Gregoriadis, ed.) p. 317, CRC Press, Boca Raton, 1993.
13. M. Grit and D. J. A. Crommelin, Chem. Phys. Lipids 64, 3 (1993).
14. E. Gerlach and B. Deuticke, Biochemische Zeitschrift 337, 477 (1963).
15. J. M. Muderhwa, N. M. Wassef, L. E. Spitler, and C. R. Alving, Vaccine Res. 5, 1 (1996).
16. A. Zlatkis, B. Zak, and A. J. Boyle, Lab. Clin. Med. 41, 486 (1953).
17. J. E. van Lier and L. L. Smith, J. Org. Chem. 35, 2627 (1970).
18. R. R. Lowry, J. Lipid Res. 9, 397 (1968).
19. C. R. Alving, R. L. Richards, M. D. Hayre, W. T. Hockmeyer, and R. A. Wirtz, in "Immunological Adjuvants and Vaccines (G. Gregoriadis, A. C. Allison, and G. Poste, eds.) p. 123, Plenum Publishing Corp., New York, 1989.
20. O. H. Lowry, N. J. Rosebrough, A. L. Farr, R. J. Randall, J. Biol. Chem. 193, 265 (1951).
21. D. Wessel and U. I. Flügge, Anal. Biochem. 138, 141 (1984).
22. U. K. Laemmli, Nature (London) 227, 680 (1970).
23. H. Towbin, T. Staehelin, and J. Gordon, Proc. Natl. Acad. Sci. USA 76, 4350 (1979).